Published in J Peripher Nerv Syst on June 01, 2007
Transient immunosuppression: a bridge between infection and the atypical autoimmunity of Guillain-Barré syndrome? Clin Exp Immunol (2010) 0.84
Oculomotor nerve palsy associated with bortezomib in a patient with multiple myeloma: a case report. J Med Case Rep (2010) 0.84
Guillain-Barré syndrome after rituximab in a patient with idiopathic thombocytopenic purpura: a causal association? J Neurol (2009) 0.83
Severe Guillain-Barré syndrome in a patient receiving anti-TNF therapy. Consequence or coincidence. A case-based review. Clin Rheumatol (2013) 0.81
Recurrent acute inflammatory demyelinating polyradiculoneuropathy following R-CHOP treatment for non-Hodgkin lymphoma. Proc (Bayl Univ Med Cent) (2013) 0.75
Guillain-Barre Syndrome in a Patient with Primary Extranodal Intestinal Non-Hodgkin's Lymphoma: Paraneoplastic, Drug Induced or Coincidental? Noro Psikiyatr Ars (2014) 0.75
Delayed-onset flaccid paralysis related to west Nile virus reactivation following treatment with rituximab: a case report. BMC Res Notes (2014) 0.75
Variant Guillain-Barré Syndrome in a Patient with Non-Hodgkin's Lymphoma. Case Rep Hematol (2015) 0.75
Polyneuropathy in POEMS syndrome: role of angiogenic factors in the pathogenesis. Brain (2005) 1.36
Anti-HuD-induced neuronal apoptosis underlying paraneoplastic gut dysmotility. Gastroenterology (2003) 1.19
Transcranial direct current stimulation (tDCS) and language. J Neurol Neurosurg Psychiatry (2012) 1.07
How useful are anti-neural IgM antibodies in the diagnosis of chronic immune-mediated neuropathies? J Neurol Sci (2007) 1.07
Cost-utility analysis of intravenous immunoglobulin and prednisolone for chronic inflammatory demyelinating polyradiculoneuropathy. Eur J Neurol (2003) 1.04
Validation of the Italian version of the Neuropathic Pain Symptom Inventory in peripheral nervous system diseases. Neurol Sci (2009) 0.98
Predictors of response to rituximab in patients with neuropathy and anti-myelin associated glycoprotein immunoglobulin M. J Peripher Nerv Syst (2007) 0.97
Pathophysiological heterogeneity of conduction blocks in multifocal motor neuropathy. Brain (2005) 0.95
Immunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathies. Cochrane Database Syst Rev (2012) 0.93
Multifocal motor neuropathy and asymptomatic Hashimoto's thyroiditis: first report of an association. Neuromuscul Disord (2002) 0.92
Transcutaneous spinal cord direct current stimulation inhibits the lower limb nociceptive flexion reflex in human beings. Pain (2010) 0.90
Chronic inflammatory demyelinating polyradiculoneuropathy and variants: where we are and where we should go. J Peripher Nerv Syst (2014) 0.90
A randomised controlled trial of intravenous immunoglobulin in IgM paraprotein associated demyelinating neuropathy. J Neurol (2002) 0.89
IVIg in idiopathic autoimmune neuropathies: analysis in the light of the latest results. J Neurol (2005) 0.88
Transcutaneous spinal direct current stimulation. Front Psychiatry (2012) 0.88
Motor nerve biopsy: clinical usefulness and histopathological criteria. Ann Neurol (2010) 0.87
Cerebellar degeneration and hearing loss in a patient with idiopathic myenteric ganglionitis. Eur J Gastroenterol Hepatol (2005) 0.86
Increased short latency afferent inhibition after anodal transcranial direct current stimulation. Neurosci Lett (2011) 0.86
Immunosuppressant and immunomodulatory treatments for multifocal motor neuropathy. Cochrane Database Syst Rev (2012) 0.86
Immunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathies. Cochrane Database Syst Rev (2016) 0.86
Bortezomib-induced peripheral neurotoxicity: still far from a painless gain. Haematologica (2007) 0.83
Multifocal motor neuropathy and Campylobacter jejuni reactivity. Neurology (2002) 0.82
Treatment for IgG and IgA paraproteinaemic neuropathy. Cochrane Database Syst Rev (2015) 0.81
Subcutaneous immunoglobulin in CIDP and MMN: a short-term nationwide study. J Neurol (2014) 0.81
Recurrent atrial fibrillation after subcutaneous apomorphine. Parkinsonism Relat Disord (2007) 0.80
Circulating levels of cytokines and their modulation by intravenous immunoglobulin in multifocal motor neuropathy. J Peripher Nerv Syst (2006) 0.78
Severe chronic sensory-motor polyneuropathy: coexistence of 3 unrelated etiologies in a type 1 diabetic patient. A case report and review of the literature. J Peripher Nerv Syst (2003) 0.78
Immunosuppressant and immunomodulatory treatments for multifocal motor neuropathy. Cochrane Database Syst Rev (2009) 0.77
The effects of levodopa and deep brain stimulation on subthalamic local field low-frequency oscillations in Parkinson's disease. Neurosignals (2012) 0.77
Subacute inflammatory demyelinating polyneuropathy disclosed by massive nerve root enhancement in CMT1A. Muscle Nerve (2011) 0.76
Chronic inflammatory demyelinating polyradiculoneuropathy and multifocal motor neuropathy: treatment update. Curr Opin Neurol (2010) 0.76
Chronic motor axonal neuropathy. J Peripher Nerv Syst (2011) 0.75
Oral methotrexate as adjunctive therapy in patients with multifocal motor neuropathy on chronic IVIg therapy. J Peripher Nerv Syst (2009) 0.75
Immunosuppressant and immunomodulatory treatments for multifocal motor neuropathy. Cochrane Database Syst Rev (2015) 0.75
Treatment dependence in chronic inflammatory demyelinating polyradiculoneuropathy: is it related to disease phenotype or to the therapy used? J Neurol Neurosurg Psychiatry (2013) 0.75
A man with low cholesterol and weakness of the lower limbs. Intern Emerg Med (2014) 0.75